Baker Avenue Asset Management, LP
Position in GOSS — Gossamer Bio, Inc.
CIK 1432529
SAN FRANCISCO, CA
Position in GOSS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,656
-$2,693 QoQ
Shares Held
10,042
-24.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#147
of 168 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $4,381,815 across 10 Biotechnology names. GOSS ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
26,219 | $1,166,483 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
13,279 | $771,908 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
2,447 | $589,653 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
931 | $580,515 | |
| 5 | RPRX |
Royalty Pharma plc
|
6,991 | $391,985 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
653 | $324,364 | |
| 7 | INCY |
Incyte Corp
|
2,148 | $243,497 | |
| 8 | EXEL |
Exelixis, Inc.
|
3,885 | $211,382 |
All Filings in GOSS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,656 | 10,042 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,349 | 13,221 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||